Why Moderna Stock Is Down 25% Over The Last Month

Why Moderna Stock Is Down 25% Over The Last Month

Share to Linkedin An illustrative image of a hand holding a medical syringe in front of the Moderna logo displayed on ... [+] a screen. On Monday, February 1, 2021, in Dublin, Ireland. (Photo by Artur Widak/NurPhoto via Getty Images) That said, there have been a couple of positive developments from Moderna, as well. Firstly, the company raised the low end of its vaccine production target for this year to 700 million doses from 600 million doses and indicated that it plans to make at least 1. 4 billion doses of the shot in 2022, with new capital investments. Moderna also indicated that it was projecting sales of about $18. 4 billion from its Covid-19 vaccine shot this year, well ahead of rival Pfizer which has forecast that its share of Covid-19 vaccine revenues would stand at roughly $15 billion in 2021. See our indicative theme of Covid-19 Vaccine stocks which includes U. S.-listed pharma and biotech companies. The theme is up about 5x over the last 2 years. [2/9/2021] Why Has Moderna Stock Rallied 75% This YearModerna stock (NASDAQ: MRNA) has rallied by over 75% since the beginning of 2021 and currently trades at levels of around $185 per